Barclays’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $356K | Buy |
|
|||||
|
2025
Q1 | $340K | Sell |
|
|||||
|
2024
Q4 | $791K | Buy |
|
|||||
|
2024
Q3 | $510K | Buy |
|
|||||
|
2024
Q2 | $344K | Buy |
|
|||||
|
2024
Q1 | $280K | Sell |
|
|||||
|
2023
Q4 | $362K | Buy |
|
|||||
|
2023
Q3 | $87K | Sell |
|
|||||
|
2023
Q2 | $144K | Sell |
|
|||||
|
2023
Q1 | $255K | Sell |
|
|||||
|
2022
Q4 | $1.02M | Buy |
|
|||||
|
2022
Q3 | $280K | Buy |
|
|||||
|
2022
Q2 | $178K | Sell |
|
|||||
|
2022
Q1 | $163K | Sell |
|
|||||
|
2021
Q4 | $480K | Buy |
|
|||||
|
2021
Q3 | $585K | Buy |
|
|||||
|
2021
Q2 | $726K | Sell |
|
|||||
|
2021
Q1 | $1.07M | Sell |
|
|||||
|
2020
Q4 | $1.45M | Buy |
|
|||||
|
2020
Q3 | $441K | Sell |
|
|||||
|
2020
Q2 | $9.5M | Buy |
|
|||||
|
2020
Q1 | $5.65M | Buy |
|
|||||
|
2019
Q4 | $6.44M | Buy |
|
|||||
|
2019
Q3 | $903K | Sell |
|
|||||
|
2019
Q2 | $1.49M | Buy |
|
|||||
|
2019
Q1 | $321K | Sell |
|
|||||
|
2018
Q4 | $520K | Buy |
|
|||||
|
2018
Q3 | $381K | Buy |
|
|||||
|
2018
Q2 | $239K | Sell |
|
|||||
|
2018
Q1 | $1.86M | Sell |
|
|||||
|
2017
Q4 | $4.33M | Buy |
|
|||||
|
2017
Q3 | $77K | Sell |
|
|||||
|
2017
Q2 | $3.6M | Buy |
|
|||||
|
2017
Q1 | $681K | Buy |
|
|||||
|
2016
Q4 | $201K | Buy |
|
|||||
|
2016
Q3 | $4K | Sell |
|
|||||
|
2016
Q2 | $4K | Buy |
|
|||||
|
2016
Q1 | $3K | Sell |
|
|||||
|
2015
Q4 | $37K | Sell |
|
|||||
|
2015
Q3 | $904K | Buy |
|
|||||
|
2015
Q2 | $397K | Buy |
|
|||||
|
2015
Q1 | $105K | Buy |
|
|||||
|
2014
Q4 | $36K | Sell |
|
|||||
|
2014
Q3 | $39K | Sell |
|
|||||
|
2014
Q2 | $53K | Buy |
|
|||||
|
2014
Q1 | $41K | Buy |
|
|||||
|
2013
Q4 | $1K | Sell |
|
|||||
|
2013
Q3 | $7K | Buy |
|